These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 30638600)
1. Allopurinol-Induced Stevens-Johnson Syndrome. Gupta SS; Sabharwal N; Patti R; Kupfer Y Am J Med Sci; 2019 Apr; 357(4):348-351. PubMed ID: 30638600 [TBL] [Abstract][Full Text] [Related]
2. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695 [TBL] [Abstract][Full Text] [Related]
3. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. Lu N; Rai SK; Terkeltaub R; Kim SC; Menendez ME; Choi HK Semin Arthritis Rheum; 2016 Oct; 46(2):253-258. PubMed ID: 27217070 [TBL] [Abstract][Full Text] [Related]
4. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China. Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979 [TBL] [Abstract][Full Text] [Related]
5. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC; J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention. Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495 [TBL] [Abstract][Full Text] [Related]
7. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population. Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531 [TBL] [Abstract][Full Text] [Related]
8. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study. Syu FK; Pan HY; Chuang PC; Huang YS; Cheng CY; Cheng FJ J Dermatol; 2018 Sep; 45(9):1080-1087. PubMed ID: 29963717 [TBL] [Abstract][Full Text] [Related]
9. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea. Lee HS; Ueta M; Kim MK; Seo KY; Sotozono C; Kinoshita S; Yoon KC Cornea; 2016 Feb; 35(2):199-204. PubMed ID: 26655481 [TBL] [Abstract][Full Text] [Related]
10. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results. Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131 [TBL] [Abstract][Full Text] [Related]
11. Rapidly Progressing Severe Cutaneous Adverse Reaction With Acute Kidney Injury After Drug Exposure: An Uncommon Presentation. Rodgers BK; Kumar AB Am J Ther; 2016; 23(3):e916-9. PubMed ID: 24832386 [TBL] [Abstract][Full Text] [Related]
12. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience. McCullough M; Burg M; Lin E; Peng D; Garner W Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629 [TBL] [Abstract][Full Text] [Related]
13. Recurrence of Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol and piroxicam. Xiong H; Liu G; Xiao J; Han Y; Liu T; Wan J; Yang J; Ding J; Dong X Eur J Dermatol; 2020 Oct; 30(5):620-621. PubMed ID: 33185537 [No Abstract] [Full Text] [Related]
14. Acute renal and hepatic failure associated with allopurinol treatment. Fagugli RM; Gentile G; Ferrara G; Brugnano R Clin Nephrol; 2008 Dec; 70(6):523-6. PubMed ID: 19049711 [TBL] [Abstract][Full Text] [Related]
15. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. Lee HY; Pang SM; Thamotharampillai T J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633 [No Abstract] [Full Text] [Related]
16. Association of human leukocyte antigen variants and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis. Li X; Zhao Z; Sun SS Am J Health Syst Pharm; 2017 May; 74(9):e183-e192. PubMed ID: 28438823 [TBL] [Abstract][Full Text] [Related]
17. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations]. Halevy S Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173 [TBL] [Abstract][Full Text] [Related]
18. A case of toxic epidermal necrolysis induced by allopurinol with human herpesvirus-6 reactivation. Watanabe Y; Matsukura S; Isoda Y; Morita A; Aihara M; Kambara T Acta Derm Venereol; 2013 Nov; 93(6):731-2. PubMed ID: 23604033 [No Abstract] [Full Text] [Related]